ArticleApplied microbiology and biotechnology2026
Metabolomic and functional profiling of Lactiplantibacillus plantarum strains reveals distinct probiotic, immunomodulatory, and antimicrobial signatures.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Functional Characterization and Probiotic Properties of Lactic Acid Bacteria Isolated from Donkey Milk.Probiotics and antimicrobial proteins · 2026Article
- Evaluating the anti-gut dysbiotic potential of bioactive primary metabolites derivatives fromFrontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Lactiplantibacillus plantarum strains are increasingly recognized for their combined probiotic and antimicrobial activities, offering potential applications in gut health management and pathogen control. This study characterized the intracellular (Met-Int) and extracellular (Met-Ext) metabolomic profiles of L. plantarum UTNGt2 (Gt2), UTNGt3 (Gt3), and UTNGt28L (Gt28L) isolated from tropical fruits and evaluated their probiotic, antimicrobial, cytotoxic, and immunomodulatory properties in vitro. Metabolomic profiling was performed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) with a SWATH (Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra) acquisition method. Cytotoxicity and cell viability were assessed by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and LDH (lactate dehydrogenase) release assays in colon epithelial cells, while cytokine responses (IL-10, IL-1β) were quantified to determine immunomodulatory effects. Antimicrobial mechanisms were examined by scanning and transmission electron microscopy (SEM/TEM) on Staphylococcus aureus ATCC1026. LC-MS/MS identified 117 Met-Int and 32 Met-Ext across the three strains, revealing shared metabolites (e.g., L-tryptophan, adenosine) and distinct strain-specific compounds (e.g., harmine, lincomycin, baicalein) associated with bioactivity. Pathway enrichment analysis indicated four enriched pathways in Gt2, eight in Gt3, and ten in Gt28L, reflecting differential specialization in amino-acid, carbohydrate, and cofactor metabolism. Gt3 exhibited the most diverse antimicrobial metabolite repertoire, whereas Gt28L showed the strongest anti-inflammatory effect, increasing IL-10 secretion by ~ 6.5-fold and reducing IL-1β by ~ 50% compared with control cells. All strains maintained > 85% cell viability with minimal LDH release. SEM/TEM analysis confirmed that Met-Ext fractions caused membrane disruption and intracellular damage in S. aureus. Overall, these results demonstrate strain-specific probiotic, antimicrobial, and immunomodulatory signatures, identifying Gt3 and Gt28L as promising candidates for therapeutic or food-grade applications. KEY POINTS: Distinct L. plantarum strains show unique metabolite profiles with probiotic potential. Gt3 and Gt28L strains exhibit strong antimicrobial and anti-inflammatory activity. Metabolite extracts disrupt pathogens while preserving epithelial cell viability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.